Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor

Molecular Pharmacology

Volumn 63, Issue 5, 2003, Pages 993-1001

  Zang, Mengwei ^a   Dong, Maoqing ^a   Pinon, Delia I ^a   Ding, Xi Qin ^a   Hadac, Elizabeth M ^a   Li, Zhijun ^b   Lybrand, Terry P ^b   Miller, Laurence J ^a  

^a MAYO CLINIC   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOGEN BROMIDE; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; PHENYLALANINE; SECRETIN; SECRETIN RECEPTOR; SKATOLE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; CONTROLLED STUDY; DRUG ACTIVITY; IMMUNOPRECIPITATION; MOLECULAR MODEL; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN DEGRADATION; RADIOIODINATION; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIMALS; CHO CELLS; CRICETINAE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOTOAFFINITY LABELS; PRECIPITIN TESTS; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; SECRETIN;

EID: 0038745566     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.5.993     Document Type: Article

References (41)

1. Alexandrov NN, Nussinov R, and Zimmer RM (1995) Fast protein fold recognition via sequence to structure alignment and contact capacity potentials. Pacific Symposium on Biocomputing '96: Hawaii, USA, 3-6 January, 1996 (Hunter L, Klein TE eds) pp 53-72, World Scientific Publishing, Singapore.
2. Asmann YW, Dong M, Ganguli S, Hadac EM, and Miller LJ (2000) Structural insights into the amino-terminus of the secretin receptor: I. Status of cysteine and cystine residues. Mol Pharmacol 58:911-919.
3. Behar V, Bisello A, Rosenblatt M, and Chorev M (1999) Direct identification of two contact sites for parathyroid hormone (PTH) in the novel PTH-2 receptor using photoaffinity cross-linking. Endocrinology 140:4251-4261.
4. Bisello A, Adams AE, Mierke DF, Pellegrini M, Rosenblatt M, Suva LJ, and Chorev M (1998) Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies. J Biol Chem 273:22498-22505.
5. Bodanszky M and Bodanszky A (1986) Conformation of Peptides of the Secretin-VIPGlucagon Family in Solution. Peptides 7(Suppl 1):43-48.
6. Cao Y-J, Gimpl G, and Fahrenholz F (1995) The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain. Biochem Biophys Res Commun 212:673-680.
7. Case DA, Pearlman DA, Caldwell JW, Cheatham TE III, Wang J, Ross WS, Simmerling CL, Darden TA, Merz KM, Stanton RV, et al. (2002) AMBER 7, Univ. of California, San Francisco.
8. Clore M, Nilges M, Brunger A, and Gronenborn AM (1988) Determination of the backbone conformation of secretin by restrained molecular dynamics on the basis of interproton distance data. Eur J Biochem 171:479-484.
9. Couvineau A, Gaudin P, Maoret J-J, Rouyer-Fessard C, Nicole P, and Laburthe M (1995) Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP. Biochem Biophys Res Commun 206:246-252.
10. Dong M, Asmann YW, Zang MW, Pinon DI, and Miller LJ (2000) Identification of two pairs of spatially approximated residues within the carboxyl terminus of secretin and its receptor. J Biol Chem 275:26032-26039.
11. Dong M, Wang Y, Hadac EM, Pinon DI, Holicky EL, and Miller LJ (1999a) Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor. J Biol Chem 274:19161-19167.
12. Dong M, Wang Y, Pinon DI, Hadac EM, and Miller LJ (1999b) Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling. J Biol Chem 274:903-909.
13. Dong M, Zang MW, Pinon DI, Li Z, Lybrand TP, and Miller LJ (2002) Interaction between four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus. Mol Endocrinol 16:2490-2501.
14. Donnelly D (1997) The arrangement of the transmembrane helices in the secretin receptor family of G-protein-coupled receptors. FEBS Lett 409:431-436.
15. Ganguli SC, Park CG, Holtmann MH, Hadac EM, Kenakin TP, and Miller LJ (1998) Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis. J Pharmacol Exp Ther 286:593-598.
16. Grauschopf U, Lilie H, Honold K, Wozny M, Reusch D, Esswein A, Schafer W, Rucknagel KP, and Rudolph R (2000) The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern. Biochemistry 39:8878-8887.
17. 261 (of the first extracellular loop) of the human PTH1 receptor. Biochemistry 39:8142-8152.
18. Hadac EM, Ghanekar DV, Holicky EL, Pinon DI, Dougherty RW, and Miller LJ (1996) Relationship between native and recombinant cholecystokinin receptors role of differential glycosylation. Pancreas 13:130-139.
19. Hadac EM, Pinon DI, Ji Z, Holicky EL, Henne R, Lybrand T, and Miller LJ (1998) Direct identification of a second distinct site of contact between cholecystokinin and its receptor. J Biol Chem 273:12988-12993.
20. Hjorth SA and Schwartz TW (1996) Glucagon and GLP-1 receptors: lessons from chimeric ligands and receptors. Acta Physiol Scand 157:343-345.
21. Holtmann MH, Ganguli S, Hadac EM, Dolu V, and Miller LJ (1996) Multiple extracellular loop domains contribute critical determinants for agonist binding and activation of the secretin receptor. J Biol Chem 271:14944-14949.
22. Holtmann MH, Hadac EM, and Miller LJ (1995) Critical contributions of aminoterminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors. J Biol Chem 270:14394-14398.
23. Horn F, Bywater R, Krause G, Kuipers W, Oliveira L, Paiva ACM, Sander C, and Vriend G (1998) The Interaction of class B G protein-coupled receptors with their hormones. Recept Channels 5:305-314.
24. Ishihara T, Nakamura S, Kaziro Y, Takahashi T, Takahashi K, and Nagata S (1991) Molecular Cloning and Expression of a CDNA Encoding the Secretin Receptor. EMBO (Eur Mol Biol Organ) J 10:1635-1641.
25. Ji TH, Grossmann M, and Ji I (1998) G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J Biol Chem 273:17299-17302.
26. Ji ZS, Hadac EM, Henne RM, Patel SA, Lybrand TP and Miller LJ (1997) Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling. J Biol Chem 272:24393-24401.
27. Jones DT, Taylor WR, and Thornton JM (1992) A new approach to protein fold recognition. Nature (Lond) 358:86-89.
28. Knudsen SM, Tams JW, Wulff BS, and Fahrenkrug J (1997) A disulfide bond between conserved cysteines in the extracellular loops of the human VIP receptor is required for binding and activation. FEBS Lett 412:141-143.
29. Kraulis PJ (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24:946-950.
30. Mannstadt M, Luck MD, Gardella TJ, and Juppner H (1998) Evidence for a ligand interaction site at the amino-terminus of the parathyroid hormone (PTH)/PTH-related protein receptor from cross-linking and mutational studies. J Biol Chem 273:16890-16896.
31. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science (Wash DC) 289:739-745.
32. Perrin MH, Fischer WH, Kunitake KS, Craig AG, Koerber SC, Cervini LA, Rivier JE, Groppe JC, Greenwald J, Moller NS, et al. (2001) Expression, purification and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor. J Biol Chem 276:31528-31534.
33. Robberecht P, Waelbroeck M, Camus JC, De Neef P, and Christophe J (1984) Importance of disulfide bonds in receptors for vasoactive intestinal peptide and secretin in rat pancreatic plasma membranes. Biochim Biophys Acta 773:271-278.
34. Sali A and Blundell TL (1993) Comparative protein modeling by satisfaction of spatial constraints. J Mol Biol 234:779-815.
35. Swanson E (1995) PSSHOW: Silicon Graphics 4D Version, Seattle, Washington.
36. Tams JW, Knudsen SM, and Fahrenkrug J (1998) Proposed arrangement of the seven transmembrane helices in the secretin receptor family. Recept Channels 5:79-90.
37. Ulrich CD, Holtmann MH, and Miller LJ (1998) Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. Gastroenterology 114:382-397.
38. Ulrich CD, Pinon DI, Hadac EM, Holicky EL, Chang-Miller A, Gates LK, and Miller LJ (1993) Intrinsic photoaffinity labeling of native and recombinant rat pancreatic secretin receptors., Gastroenterology 105:1534-1543.
39. Vilardaga J-P, De Neef P, Di Paolo E, Bollen A, Waelbroeck M, and Robberecht P (1995) Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. Biochem Biophys Res Commun 211:885-891.
40. Vilardaga JP, Di Paolo E, Bialek C, De Neef P, Waelbroeck M, Bollen A, and Robberecht P (1997) Mutational analysis of extracellular cysteine residues of rat secretin receptor shows that disulfide bridges are essential for receptor function. Eur J Biochem 246:173-180.
41. Vilardaga JP, Lin I, and Nissenson RA (2001) Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the PTH/PTH-related peptide (PTHrP) receptor on hormone binding and receptor activation. Mol Endocrinol 15:1186-1199.